InChI=1S/C44H82NO8P/c1- 6- 8- 10- 12- 14- 16- 18- 20- 21- 22- 23- 25- 27- 29- 31- 33- 35- 37- 44(47) 53- 42(41- 52- 54(48,49) 51- 39- 38- 45(3,4) 5) 40- 50- 43(46) 36- 34- 32- 30- 28- 26- 24- 19- 17- 15- 13- 11- 9- 7- 2/h14,16,20- 21,23,25,42H,6- 13,15,17- 19,22,24,26- 41H2,1- 5H3/b16- 14- ,21- 20- ,25- 23- /t42- /m1/s1 |
SRIGHEHXEGELQJ-YYQUKWHJSA-N |
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/CCCCC |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 36:3 )
|
|
View more via ChEBI Ontology
Outgoing
|
1- hexadecanoyl- 2- [(8Z,11Z,14Z)- eicosatrienoyl]- sn- glycero- 3- phosphocholine
(CHEBI:86121)
has functional parent
all-cis-icosa-8,11,14-trienoic acid
(CHEBI:53486)
1- hexadecanoyl- 2- [(8Z,11Z,14Z)- eicosatrienoyl]- sn- glycero- 3- phosphocholine
(CHEBI:86121)
has functional parent
hexadecanoic acid
(CHEBI:15756)
1- hexadecanoyl- 2- [(8Z,11Z,14Z)- eicosatrienoyl]- sn- glycero- 3- phosphocholine
(CHEBI:86121)
is a
1-palmitoyl-2-icosatrienoyl-sn-glycero-3-phosphocholine
(CHEBI:133631)
|
|
(2R)- 3- (hexadecanoyloxy)- 2- {[(8Z,11Z,14Z)- icosa- 8,11,14- trienoyl]oxy}propyl 2- (trimethylazaniumyl)ethyl phosphate
|
1-hexadecanoyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine
|
UniProt
|
1-Palmitoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphocholine
|
HMDB
|
GPCho(16:0/20:3)
|
HMDB
|
GPCho(16:0/20:3n6)
|
HMDB
|
GPCho(16:0/20:3w6)
|
HMDB
|
PC(16:0/20:3(8Z,11Z,14Z))
|
LIPID MAPS
|
PC(16:0/20:3)
|
HMDB
|
PC(16:0/20:3n6)
|
HMDB
|
PC(16:0/20:3w6)
|
HMDB
|
Phosphatidylcholine(16:0/20:3n6)
|
HMDB
|
Phosphatidylcholine(16:0/20:3w6)
|
HMDB
|
|